(ENDP) Endo Pharmaceuticals Hits FDA Roadblock With Aveed
Endo Pharmaceuticals (ENDP) hit a roadblock related to the approval of Aveed. Recently, the company received a complete response letter (CRL) from the US Food and Drug Administration (FDA) regarding...
View Article(LLY) Eli Lilly and Company Expands Men’s Health Range
Eli Lilly and Co. (LLY) recently entered into a deal with Australian company, Acrux, which should help strengthen Lilly’s men’s health portfolio. Lilly acquired exclusive worldwide rights to...
View Article(ENDP) Endo Pharmaceuticals – PEG Ratio Also Shows a Bargain at 0.7
Endo Pharmaceuticals (ENDP) continues to trade at great valuations and have plenty of earnings momentum. Company Description Endo Pharmaceuticals makes branded and generic drugs to treat and manage...
View Article(ENDP) Endo Pharmaceuticals Holdings to Buy Penwest Pharmaceuticals
In a bid to sustain and drive growth in the area of pain management, Endo Pharmaceuticals Holdings Inc. (ENDP) recently agreed to acquire drug developer Penwest Pharmaceuticals Co. (PPCO). Through this...
View Article(AAPL) Company News for September 28, 2010 – Corporate Summary
• Walgreen (NYSE:WAG) reported better-than-expected fiscal fourth quarter earnings of 49 cents a share, five cents higher than estimates, on revenues of $16.87 billion, up 7.4% versus last year • Jabil...
View Article(APC) Company News for December 30, 2010 – Corporate Summary
• BHP Billiton (NYSE:BHP) plans to offer a price of $90 per share for Anadarko (NYSE:APC) • Lockheed Martin (NYSE:LMT) was awarded a Navy contract yesterday to build 10 warships known as Littoral...
View Article(LLY) Eli Lilly’s Axiron Testosterone Deficiency Drug Launched in the U.S.
Eli Lilly and Company (LLY) recently announced the availability of Axiron in pharmacies across the US. Axiron gained approval from the US Food and Drug Administration (FDA) in November 2010 for use as...
View Article(AA) Company News for April 12, 2011 – Corporate Summary
• Level 3 Communications (NASDAQ:LVLT) and Global Crossing Limited (NASDAQ:GLBC) have entered into a agreement under which Level 3 will acquire Global Crossing in a stock-for-stock transaction • Endo...
View Article(ENDP) Endo Pharmaceuticals Holdings to Take Over American Medical Systems
In a bid to diversify its business and bolster its urology portfolio, Endo Pharmaceuticals Holdings Inc. (ENDP), a US-based specialty healthcare solutions company which develops branded products and...
View Article(ABT) Abbott Laboratories Earns FDA Approval of AndroGel
Abbott Laboratories (ABT) recently gained US Food and Drug Administration (FDA) approval for AndroGel (testosterone gel) 1.62%. The gel formulation is approved for the treatment of hypogonadism (low or...
View Article(AMMD) American Medical Systems Analyst Maintains Neutral Rating on Shares
We maintain our Neutral recommendation on leading pelvic-health devices maker American Medical Systems (AMMD). Its first-quarter fiscal 2011 earnings of 33 cents per share beat the Zacks Consensus...
View Article(ENDP) Endo Pharmaceuticals Evenly Poised
We are maintaining our Neutral stance on Endo Pharmaceuticals (ENDP) with a target price of $44.00. Headquartered in Chadds Ford, Pennsylvania and founded in 1997, Endo Pharma is a specialty healthcare...
View Article(AMMD) American Medical Systems Starts Implant Registry
Leading pelvic-health devices maker American Medical Systems (AMMD) recently initiated a large-scale global registry of penile prosthetic outcomes. The new registry, dubbed PROPPER (Prospective...
View Article(ENDP) Endo Pharmaceuticals Holdings Buys American Medical
Recently, Endo Pharmaceuticals Holdings Inc. (ENDP) completed the purchase of American Medical Systems, a leading pelvic-health device provider, in an all cash deal worth approximately $2.9 billion. By...
View Article(ENDP) Endo Pharmaceuticals Announces FDA Action Date
Endo Pharmaceuticals (ENDP) recently announced that the US Food and Drug Administration (FDA) has issued a new action date for the new formulation of painkiller Opana ER. The FDA stated that it will...
View Article(ENDP) Endo Pharmaceuticals’ Back Pain Drug Disappoints
Endo Pharmaceuticals (ENDP) recently suffered a pipeline setback with its candidate axomadol performing disappointingly in a mid-stage trial (n=236). Top line results from the study revealed that Endo...
View Article(MYL) Mylan and Endo Pharmaceuticals in Legal Tussle
Mylan Inc. (MYL) recently announced that Endo Pharmaceuticals (ENDP) filed a patent infringement lawsuit in connection with an abbreviated new drug application (ANDA) filed by Mylan with the US Food...
View Article(EU) Pharmaceuticals Stock Outlook – September 2011 – Industry Outlook
The pharmaceutical industry continues to be impacted by major issues such as sluggish prescription trends, European Union (EU) pricing pressure, intensifying generic competition and limited late-stage...
View Article(DTG) Company News for December 13, 2011 – Corporate Summary
• Car rental company Dollar Thrifty Automotive Group (NYSE:DTG) said the company’s CEO and President Mr. Scott L. Thompson will take over the role of Chairman of the Board of Directors with...
View Article(ENDP) Endo Health Solutions Announces Good News on Pain Portfolio
Endo Health Solutions (ENDP) recently announced that the transition of the company’s Opana ER franchise to the new version, which is designed to be crush resistant, is complete. The new version of the...
View Article
